The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaginal Fungi Infections Treatment Market Research Report 2025
Synopsis
Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.
The global Vaginal Fungi Infections Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaginal Fungi Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Fungi Infections Treatment.
Report Scope
The Vaginal Fungi Infections Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaginal Fungi Infections Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaginal Fungi Infections Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS
Segment by Type
Fluconazole
Nystatin
Flucytosine
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaginal Fungi Infections Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.
The global Vaginal Fungi Infections Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaginal Fungi Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Fungi Infections Treatment.
Report Scope
The Vaginal Fungi Infections Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaginal Fungi Infections Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaginal Fungi Infections Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS
Segment by Type
Fluconazole
Nystatin
Flucytosine
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaginal Fungi Infections Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fluconazole
1.2.3 Nystatin
1.2.4 Flucytosine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaginal Fungi Infections Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaginal Fungi Infections Treatment Market Perspective (2019-2030)
2.2 Vaginal Fungi Infections Treatment Growth Trends by Region
2.2.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaginal Fungi Infections Treatment Historic Market Size by Region (2019-2024)
2.2.3 Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2025-2030)
2.3 Vaginal Fungi Infections Treatment Market Dynamics
2.3.1 Vaginal Fungi Infections Treatment Industry Trends
2.3.2 Vaginal Fungi Infections Treatment Market Drivers
2.3.3 Vaginal Fungi Infections Treatment Market Challenges
2.3.4 Vaginal Fungi Infections Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue
3.1.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue (2019-2024)
3.1.2 Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Vaginal Fungi Infections Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaginal Fungi Infections Treatment Revenue
3.4 Global Vaginal Fungi Infections Treatment Market Concentration Ratio
3.4.1 Global Vaginal Fungi Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaginal Fungi Infections Treatment Revenue in 2023
3.5 Vaginal Fungi Infections Treatment Key Players Head office and Area Served
3.6 Key Players Vaginal Fungi Infections Treatment Product Solution and Service
3.7 Date of Enter into Vaginal Fungi Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaginal Fungi Infections Treatment Breakdown Data by Type
4.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Type (2019-2024)
4.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2025-2030)
5 Vaginal Fungi Infections Treatment Breakdown Data by Application
5.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Application (2019-2024)
5.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaginal Fungi Infections Treatment Market Size (2019-2030)
6.2 North America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaginal Fungi Infections Treatment Market Size by Country (2019-2024)
6.4 North America Vaginal Fungi Infections Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaginal Fungi Infections Treatment Market Size (2019-2030)
7.2 Europe Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaginal Fungi Infections Treatment Market Size by Country (2019-2024)
7.4 Europe Vaginal Fungi Infections Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaginal Fungi Infections Treatment Market Size (2019-2030)
8.2 Asia-Pacific Vaginal Fungi Infections Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaginal Fungi Infections Treatment Market Size (2019-2030)
9.2 Latin America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaginal Fungi Infections Treatment Market Size by Country (2019-2024)
9.4 Latin America Vaginal Fungi Infections Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2019-2030)
10.2 Middle East & Africa Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.1.5 Pfizer Inc. Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Detail
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Introduction
11.2.4 Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 ANI Pharmaceuticals
11.3.1 ANI Pharmaceuticals Company Detail
11.3.2 ANI Pharmaceuticals Business Overview
11.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Introduction
11.3.4 ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.3.5 ANI Pharmaceuticals Recent Development
11.4 Hikma Pharmaceuticals Plc
11.4.1 Hikma Pharmaceuticals Plc Company Detail
11.4.2 Hikma Pharmaceuticals Plc Business Overview
11.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Introduction
11.4.4 Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.4.5 Hikma Pharmaceuticals Plc Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Detail
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Vaginal Fungi Infections Treatment Introduction
11.5.4 Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.5.5 Lupin Limited Recent Development
11.6 Mycovia Pharmaceuticals
11.6.1 Mycovia Pharmaceuticals Company Detail
11.6.2 Mycovia Pharmaceuticals Business Overview
11.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Introduction
11.6.4 Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.6.5 Mycovia Pharmaceuticals Recent Development
11.7 Glenmark Pharmaceuticals Limited
11.7.1 Glenmark Pharmaceuticals Limited Company Detail
11.7.2 Glenmark Pharmaceuticals Limited Business Overview
11.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Introduction
11.7.4 Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.7.5 Glenmark Pharmaceuticals Limited Recent Development
11.8 Unique Pharmaceuticals
11.8.1 Unique Pharmaceuticals Company Detail
11.8.2 Unique Pharmaceuticals Business Overview
11.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Introduction
11.8.4 Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.8.5 Unique Pharmaceuticals Recent Development
11.9 PEPTONIC medical AB
11.9.1 PEPTONIC medical AB Company Detail
11.9.2 PEPTONIC medical AB Business Overview
11.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Introduction
11.9.4 PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.9.5 PEPTONIC medical AB Recent Development
11.10 Aurobindo Pharma Limited
11.10.1 Aurobindo Pharma Limited Company Detail
11.10.2 Aurobindo Pharma Limited Business Overview
11.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Introduction
11.10.4 Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.10.5 Aurobindo Pharma Limited Recent Development
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Detail
11.11.2 Dr. Reddy's Laboratories Business Overview
11.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Introduction
11.11.4 Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.11.5 Dr. Reddy's Laboratories Recent Development
11.12 SCYNEXIS
11.12.1 SCYNEXIS Company Detail
11.12.2 SCYNEXIS Business Overview
11.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Introduction
11.12.4 SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2019-2024)
11.12.5 SCYNEXIS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fluconazole
Table 3. Key Players of Nystatin
Table 4. Key Players of Flucytosine
Table 5. Key Players of Others
Table 6. Global Vaginal Fungi Infections Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Vaginal Fungi Infections Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Vaginal Fungi Infections Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Vaginal Fungi Infections Treatment Market Share by Region (2019-2024)
Table 10. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Vaginal Fungi Infections Treatment Market Share by Region (2025-2030)
Table 12. Vaginal Fungi Infections Treatment Market Trends
Table 13. Vaginal Fungi Infections Treatment Market Drivers
Table 14. Vaginal Fungi Infections Treatment Market Challenges
Table 15. Vaginal Fungi Infections Treatment Market Restraints
Table 16. Global Vaginal Fungi Infections Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Vaginal Fungi Infections Treatment Market Share by Players (2019-2024)
Table 18. Global Top Vaginal Fungi Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2023)
Table 19. Ranking of Global Top Vaginal Fungi Infections Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Vaginal Fungi Infections Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Vaginal Fungi Infections Treatment Product Solution and Service
Table 23. Date of Enter into Vaginal Fungi Infections Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vaginal Fungi Infections Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Vaginal Fungi Infections Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Vaginal Fungi Infections Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Vaginal Fungi Infections Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Vaginal Fungi Infections Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Vaginal Fungi Infections Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Inc. Company Detail
Table 49. Pfizer Inc. Business Overview
Table 50. Pfizer Inc. Vaginal Fungi Infections Treatment Product
Table 51. Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 52. Pfizer Inc. Recent Development
Table 53. Bausch Health Companies Inc Company Detail
Table 54. Bausch Health Companies Inc Business Overview
Table 55. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product
Table 56. Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 57. Bausch Health Companies Inc Recent Development
Table 58. ANI Pharmaceuticals Company Detail
Table 59. ANI Pharmaceuticals Business Overview
Table 60. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product
Table 61. ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 62. ANI Pharmaceuticals Recent Development
Table 63. Hikma Pharmaceuticals Plc Company Detail
Table 64. Hikma Pharmaceuticals Plc Business Overview
Table 65. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product
Table 66. Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 67. Hikma Pharmaceuticals Plc Recent Development
Table 68. Lupin Limited Company Detail
Table 69. Lupin Limited Business Overview
Table 70. Lupin Limited Vaginal Fungi Infections Treatment Product
Table 71. Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 72. Lupin Limited Recent Development
Table 73. Mycovia Pharmaceuticals Company Detail
Table 74. Mycovia Pharmaceuticals Business Overview
Table 75. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product
Table 76. Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 77. Mycovia Pharmaceuticals Recent Development
Table 78. Glenmark Pharmaceuticals Limited Company Detail
Table 79. Glenmark Pharmaceuticals Limited Business Overview
Table 80. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product
Table 81. Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 82. Glenmark Pharmaceuticals Limited Recent Development
Table 83. Unique Pharmaceuticals Company Detail
Table 84. Unique Pharmaceuticals Business Overview
Table 85. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product
Table 86. Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 87. Unique Pharmaceuticals Recent Development
Table 88. PEPTONIC medical AB Company Detail
Table 89. PEPTONIC medical AB Business Overview
Table 90. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product
Table 91. PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 92. PEPTONIC medical AB Recent Development
Table 93. Aurobindo Pharma Limited Company Detail
Table 94. Aurobindo Pharma Limited Business Overview
Table 95. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product
Table 96. Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 97. Aurobindo Pharma Limited Recent Development
Table 98. Dr. Reddy's Laboratories Company Detail
Table 99. Dr. Reddy's Laboratories Business Overview
Table 100. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product
Table 101. Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 102. Dr. Reddy's Laboratories Recent Development
Table 103. SCYNEXIS Company Detail
Table 104. SCYNEXIS Business Overview
Table 105. SCYNEXIS Vaginal Fungi Infections Treatment Product
Table 106. SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2019-2024) & (US$ Million)
Table 107. SCYNEXIS Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaginal Fungi Infections Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Vaginal Fungi Infections Treatment Market Share by Type: 2023 VS 2030
Figure 3. Fluconazole Features
Figure 4. Nystatin Features
Figure 5. Flucytosine Features
Figure 6. Others Features
Figure 7. Global Vaginal Fungi Infections Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Vaginal Fungi Infections Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Vaginal Fungi Infections Treatment Report Years Considered
Figure 13. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Vaginal Fungi Infections Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Vaginal Fungi Infections Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Vaginal Fungi Infections Treatment Market Share by Players in 2023
Figure 17. Global Top Vaginal Fungi Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Fungi Infections Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Vaginal Fungi Infections Treatment Revenue in 2023
Figure 19. North America Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Vaginal Fungi Infections Treatment Market Share by Country (2019-2030)
Figure 21. United States Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Vaginal Fungi Infections Treatment Market Share by Country (2019-2030)
Figure 25. Germany Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Region (2019-2030)
Figure 33. China Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Vaginal Fungi Infections Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Vaginal Fungi Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Pfizer Inc. Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 48. Bausch Health Companies Inc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 49. ANI Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 50. Hikma Pharmaceuticals Plc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 51. Lupin Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 52. Mycovia Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 53. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 54. Unique Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 55. PEPTONIC medical AB Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 56. Aurobindo Pharma Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 57. Dr. Reddy's Laboratories Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 58. SCYNEXIS Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
